Review article: from 1906 to 2006 – a century of major evolution of understanding of gastro‐oesophageal reflux disease

• Published in: Alimentary pharmacology & therapeutics Vol. 24; no. 9; pp. 1269 - 1281
• Main Author: DENT, J.
• Format: Journal Article
• Language: English
• Published: Oxford, UK Blackwell Publishing Ltd 01-11-2006; Blackwell
• Subjects: Barrett Esophagus - history; Biological and medical sciences; Digestive system; Equipment Design; Esophagus; Gastroenterology. Liver. Pancreas. Abdomen; Gastroesophageal Reflux - history; History, 20th Century; History, 21st Century; Humans; Medical sciences; Other diseases. Semiology; Pharmacology. Drug treatments; Gastroesophageal reflux; Digestive diseases; Evolution; Review; Bibliographic review; Esophageal disease
• ISSN: 0269-2813; 1365-2036
• DOI: 10.1111/j.1365-2036.2006.03122.x

Summary
Background
Our understanding of gastro‐oesophageal reflux disease has undergone significant changes over the last century.
Aim
To trace the rise in understanding of gastro‐oesophageal reflux disease and highlight remaining areas of uncertainty.
Methods
Literature review.
Results
In 1906, Tileston published his observations on ‘peptic ulcer of the oesophagus’. Winkelstein, in 1934, first correlated symptoms of heartburn with acid regurgitation and reflux oesophagitis. In 1946, Allison described hiatus hernia as a causal factor in the development of gastro‐oesophageal reflux disease. In 1958, Bernstein and Baker showed a direct relationship between oesophageal acidification and heartburn in patients with gastro‐oesophageal reflux disease, irrespective of endoscopic findings, leading to the recognition of non‐erosive gastro‐oesophageal reflux disease. In the 1980s, continuous recordings of the lower oesophageal sphincter showed that episodes of reflux were related to transient relaxations of lower oesophageal sphincter tone. There is now increasing recognition that gastro‐oesophageal reflux disease arises from the interaction of several anatomical and physiological factors. A turning point in the medical treatment of gastro‐oesophageal reflux disease came with the introduction of the first proton pump inhibitor, omeprazole, in 1989.
Conclusions
Future efforts need to identify the multifactorial interactions of gastro‐oesophageal junction anatomy and physiology in patients with gastro‐oesophageal reflux disease. Increased understanding of the disease will guide development of new therapies.